Evidence map›Paper›PMID 35305969›Full record

ArticleChest2022

Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease.

Rebecca A Gersten, Bhavna Seth, Luis Arellano, Jessica Shore, Lanier O'Hare, Nina Patel, Zeenat Safdar, Rachana Krishna, Yolanda Mageto, Darlene Cochran and 3 more

Open access · greenAbstract read
In one paragraph

Article in Chest, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Rebecca A GerstenDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD. Electronic address: rgerste4@jhu.edu.
Bhavna SethDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD.
Luis ArellanoPulmonary Fibrosis Foundation, Chicago, IL.
Jessica ShorePulmonary Fibrosis Foundation, Chicago, IL.
Lanier O'HareUniversity of Alabama at Birmingham, Birmingham, AL.
Nina PatelDivision of Pulmonary and Critical Care Medicine, Columbia University Medical Center, New York, NY.
Zeenat SafdarDivision of Pulmonary and Critical Care Medicine, Houston Methodist Academic Institute, Houston, TX.
Rachana KrishnaDivision of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC.
Yolanda MagetoDivision of Pulmonary and Critical Care Medicine, Baylor University Medical Center, Dallas, TX.
Darlene CochranPulmonary Fibrosis Foundation, Chicago, IL.
Kathleen LindellCollege of Nursing, Medical University of South Carolina, Charleston, SC.
Sonye K DanoffDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD; Pulmonary Fibrosis Foundation, Chicago, IL.
Pulmonary Fibrosis Foundation
Johns Hopkins University · USMedical University of South Carolina · USPulmonary Fibrosis Foundation · USColumbia University Irving Medical Center · USBaylor University Medical Center · USHouston Methodist · USUniversity of Alabama at Birmingham · US

Funding

MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Nadia N Hansel, Larissa A. Shimoda · 1985 to 2026
$28.3M
NHLBI NIH HHS T32 HL007534
6 · The paper itself

Abstract

backgroundInterstitial lung disease (ILD) results in profound symptom burden and carries high mortality. Palliative care (PC) is dedicated to improving quality of life in patients with serious illness. Early PC provision improves rates of advance care planning and symptom management in patients with ILD. RESEARCH QUESTION: What are the current perspectives on PC among ILD providers, and what are the barriers to PC in ILD specialty centers? STUDY DESIGN AND

methodsA 24-question electronic survey was disseminated to providers at the 68 Pulmonary Fibrosis Foundation Care Centers across the United States from October 2020 to December 2020.

resultsThe survey was completed by 128 participants representing all 68 Pulmonary Fibrosis Foundation Care Center Network sites. Most respondents were physicians. Most providers exhibit good knowledge of, feel comfortable assessing a patient's readiness for, and agree with the need for PC for patients with ILD. Providers are most likely to refer to PC at objective disease and/or symptomatic progression rather than at initial diagnosis. In comparison with providers who report referring their patients to PC, providers who report rare referral are more likely to cite lack local PC availability (P < .01) and less likely to feel comfortable discussing prognosis/disease trajectory (P = .03) or feel it is important to address advance directives in ILD clinic (P = .02). There is a lack of standardized measures used to assess specific symptoms, overall symptom burden, or health-related quality of life across institutions. Discordance exists between self-reported and actual access to local inpatient and outpatient PC services.

interpretationMost ILD providers use PC and are comfortable discussing PC. Barriers to PC identified in this survey include the following: perceived lack of local access to PC, lack of systematic tools to assess symptom burden, lack of established optimal timing of PC referral, and unclear need for specialized PC delivery.

Indexed as

Hospice and Palliative Care NursingLung Diseases, InterstitialPulmonary FibrosisHumansPalliative CareQuality of LifeUnited Statesinterstitial lung diseasepalliative carepulmonary fibrosis

Identifiers

PMID35305969
PMCPMC9633804
OpenAlexW4220999684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.